APW
ADPT icon

Atlantic Private Wealth’s Adaptive Biotechnologies ADPT Stock Holding History

Atlantic Private Wealth’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322 Hold
15
– – ﹤0.01% 287
2026
Q1 		$208 Hold
15
– – ﹤0.01% 309
2025
Q4 		$244 Buy
+15
New +$245 ﹤0.01% 378

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Atlantic Private Wealth's ADPT Position: Q2 2026 in Review

Atlantic Private Wealth held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 15 shares worth $322. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Atlantic Private Wealth first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Atlantic Private Wealth held 15 shares of Adaptive Biotechnologies worth $322 as of Q2 2026.
  • Atlantic Private Wealth left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q2 2026, its #287 holding.
  • Atlantic Private Wealth first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Atlantic Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.